Want to see JP:4480 full AI Analyst Report?
4480 Stock Chart & Stats
¥2340.00
-¥75.00(-2.00%)
At close: 4:00 PM EST
¥2340.00
-¥75.00(-2.00%)
Day’s Range― - ―
52-Week Range¥1,715.00 - ¥3,040.00
Previous CloseN/A
Volume195.70K
Average Volume (3M)214.92K
Market Cap
¥76.87B
Enterprise Value¥68.23B
Total Cash (Recent Filing)¥12.04B
Total Debt (Recent Filing)¥18.83B
Price to Earnings (P/E)41.4
Beta0.44
Next Earnings
Nov 12, 2026EPS Estimate
7.87Next Dividend Ex-DateN/A
Dividend Yield0%
Share Statistics
EPS (TTM)60.12
Shares Outstanding31,808,600
10 Day Avg. Volume228,410
30 Day Avg. Volume214,920
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)5.08
Price to Sales (P/S)2.04
P/FCF Ratio22.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)82.94
Revenue Forecast (FY)¥46.28B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe substantial multi-year increase in revenue indicates sustained expansion in the company’s healthcare information services business. Continued top-line growth can broaden its operating scale, support investment in products and capabilities, and provide a durable foundation for future earnings recovery.
Healthy Gross MarginA gross margin near 63% suggests the company retains meaningful economic value after direct costs. This provides room to fund technology, sales, and service development while preserving the potential for improved operating profitability if expense growth becomes more disciplined.
Positive Cash GenerationPositive operating and free cash flow, together with close earnings-to-cash conversion, indicates that reported profits are generally supported by cash generation. This improves the company’s ability to fund investment and meet obligations without relying entirely on external financing.
Bears Say
Sharp Margin CompressionThe sharp decline in net margin shows that strong gross profitability has not translated into stable bottom-line performance. If the pressure persists, it could reduce internally generated capital, limit operating flexibility, and make future earnings more sensitive to cost control.
Higher LeverageThe rise in debt relative to equity has materially reduced the balance-sheet cushion compared with earlier years. Greater leverage can constrain capital allocation, increase financial risk during weaker operating periods, and make the company more dependent on sustained cash generation.
Cash Flow VolatilityAlthough cash generation was positive in 2025, the prior decline in free cash flow and modest conversion relative to operating profit point to variability in cash realization. Such fluctuations may complicate investment planning and reduce the predictability of funding available for growth.
Medley News
4480 FAQ
What was Medley, Inc.’s price range in the past 12 months?
Medley, Inc. lowest stock price was ¥1715.00 and its highest was ¥3040.00 in the past 12 months.
What is Medley, Inc.’s market cap?
Medley, Inc.’s market cap is ¥76.87B.
When is Medley, Inc.’s upcoming earnings report date?
Medley, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 21 days.
How were Medley, Inc.’s earnings last quarter?
Medley, Inc. released its earnings results on Aug 13, 2026. The company reported ¥51.53 earnings per share for the quarter, beating the consensus estimate of ¥46 by ¥5.53.
Is Medley, Inc. overvalued?
According to Wall Street analysts Medley, Inc.’s price is currently Overvalued.
Does Medley, Inc. pay dividends?
Medley, Inc. pays a Notavailable dividend of ¥18 which represents an annual dividend yield of 0%. See more information on Medley, Inc. dividends here
What is Medley, Inc.’s EPS estimate?
Medley, Inc.’s EPS estimate is 7.87.
How many shares outstanding does Medley, Inc. have?
Medley, Inc. has 31,808,600 shares outstanding.
What happened to Medley, Inc.’s price movement after its last earnings report?
Medley, Inc. reported an EPS of ¥51.53 in its last earnings report, beating expectations of ¥46. Following the earnings report the stock price went up 1.919%.
Which hedge fund is a major shareholder of Medley, Inc.?
Currently, no hedge funds are holding shares in JP:4480
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medley, Inc.
Medley, Inc., a company based in Japan, develops and manages digital platforms for both the recruitment and medical industries. Its operations are structured into three primary segments: HR Platform Business, Medical Platform Business, and New Services. The firm's portfolio of offerings includes JobMedley, a human resources recruitment system specifically for medical, healthcare, and related sectors; CLINICS Telemedicine, a system enabling virtual consultations between patients and healthcare providers; CLINICS, a cloud-based platform for medical facility support; Pharms, which provides support systems for pharmacy front-desk operations; MEDLEY, a service offering medical information to patients; and Kaigo-no Honne, an online portal for searching nursing care facilities. Additionally, Medley, Inc. undertakes proof-of-concept testing for its Pharms solutions. The company was established in 2009 and maintains its corporate headquarters in Tokyo, Japan.